Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

Sep 10, 2018

Exposomics in PSC Research

By Konstantinos N. Lazaridis, M.D., @klazaridis



A major goal of our current research for Primary Sclerosing Cholangitis (PSC) involves capturing “the exposome,” or the role of environmental exposures – pollutants, pesticides, medication, diet, etc. – and the associated biological responses to these exposures.

In this video, Mayo Clinic hepatologist, Dr. Konstantinos Lazaridis explains what the exposome is and discusses the significance of this work in elucidating how PSC develops.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

Please login or register to send an invite.